Patents by Inventor Bo Angelin

Bo Angelin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IBAT INHIBITORS FOR TREATMENT OF METABOLIC DISORDERS AND RELATED CONDITIONS
    Publication number: 20120114588
    Abstract: The present invention regards specific IBAT inhibitors with improved effect in prophylaxis and treatment of metabolic syndrome, obesity, disorders of fatty acid metabolism, glucose utilization disorders, disorders in which insulin resistance is involved, diabetes mellitus, type 1 and type 2 diabetes. It also relates to compositions comprising these IBAT inhibitors, a method for treatment of the disorders and a kit comprising the substances or the compositions.
    Type: Application
    Filed: May 26, 2011
    Publication date: May 10, 2012
    Applicant: ALBIREO AB
    Inventors: Ingemar Starke, Hans Graffner, Per-Göran Gillberg, Ann-Margret Lindqvist, Bo Angelin
  • Estrogen receptors
    Publication number: 20060211671
    Abstract: This invention relates to the field of estrogen receptors and particularly though not exclusively on the effect of estrogen receptors and ligands for estrogen receptors on the prevention or treatment of obesity. The invention also relates to the effect of estrogen receptors and their ligands on lipoprotein levels in mammals.
    Type: Application
    Filed: September 30, 2005
    Publication date: September 21, 2006
    Inventors: Claes Ohlsson, Jan-Ake Gustafsson, Margaret Warner, Bo Angelin
  • Estrogen receptors
    Publication number: 20040214769
    Abstract: This invention relates to the field of estrogen receptors and particularly though not exclusively on the effect of estrogen receptors and ligands for estrogen receptors on the prevention or treatment of obesity. The invention also relates to the effect of estrogen receptors and their ligands on lipoprotein levels in mammals.
    Type: Application
    Filed: January 6, 2004
    Publication date: October 28, 2004
    Inventors: Claes Ohlsson, Jan-Ake Gustafsson, Margaret Warner, Bo Angelin
  • Use of growth hormone or analogues thereof for the treatment of mammals with familial hypercholesterolemia
    Patent number: 6559289
    Abstract: The invention relates to the use of compounds selected from GH, analogues thereof, and GH-releasing compounds, optionally in combination with lipid-lowering agents or therapy, for the preparation of a drug for treatment of mammals with familial hypercholesterolemia of homozygous form.
    Type: Grant
    Filed: April 23, 2001
    Date of Patent: May 6, 2003
    Assignee: Salhtech I Goteborg AB
    Inventors: Mats Rudling, Bo Angelin
  • Estrogen receptors
    Publication number: 20020151732
    Abstract: This invention relates to the field of estrogen receptors and particularly though not exclusively on the effect of estrogen receptors and ligands for estrogen receptors on the prevention or treatment of obesity. The invention also relates to the effect of estrogen receptors and their ligands on lipoprotein levels in mammals.
    Type: Application
    Filed: November 26, 2001
    Publication date: October 17, 2002
    Inventors: Claes Ohlsson, Jan-Ake Gustafsson, Margaret Warner, Bo Angelin